BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17610264)

  • 21. [Dynamic stress echocardiography in asymptomatic patients treated for malignant diseases in childhood].
    Elbl L; Hrstková H; Chaloupka V; Novotný J
    Vnitr Lek; 2003 Apr; 49(4):273-9. PubMed ID: 12793049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline].
    Yildirim A; Tunaoğlu FS; Pinarli FG; Ilhan M; Oğuz A; Karadeniz C; Olguntürk R; Oğuz D; Kula S
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):154-62. PubMed ID: 20382616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiorespiratory status after treatment for acute lymphoblastic leukemia.
    Turner-Gomes SO; Lands LC; Halton J; Hanning RM; Heigenhauser GJ; Pai M; Barr R
    Med Pediatr Oncol; 1996 Mar; 26(3):160-5. PubMed ID: 8544797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation.
    Link K; Moëll C; Osterberg K; Persson R; Ørbaek P; Garwicz S; Cavallin-Ståhl E; Erfurth EM
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):617-25. PubMed ID: 17054463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia.
    Christiansen JR; Massey R; Dalen H; Kanellopoulos A; Hamre H; Ruud E; Kiserud CE; Fosså SD; Aakhus S
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):735-41. PubMed ID: 26917232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up.
    Oztarhan K; Guler S; Aktas B; Arslan M; Salcioglu Z; Aydogan G
    Pediatr Hematol Oncol; 2011 Aug; 28(5):380-94. PubMed ID: 21699467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors.
    De Wolf D; Suys B; Maurus R; Benoit Y; Verhaaren H; Matthijs D; Otten J
    Pediatr Res; 1996 Mar; 39(3):504-12. PubMed ID: 8929873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors.
    Amigoni M; Giannattasio C; Fraschini D; Galbiati M; Capra AC; Madotto F; Cesana F; Jankovic M; Masera G; Mancia G
    Pediatr Blood Cancer; 2010 Dec; 55(7):1343-7. PubMed ID: 20589666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines.
    Mladosievicova B; Urbanova D; Radvanska E; Slavkovsky P; Simkova I
    J Exp Clin Cancer Res; 2012 Oct; 31(1):86. PubMed ID: 23057994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.
    Vandecruys E; Mondelaers V; De Wolf D; Benoit Y; Suys B
    J Cancer Surviv; 2012 Mar; 6(1):95-101. PubMed ID: 21630046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood.
    Prestor VV; Rakovec P; Kozelj M; Jereb B
    Pediatr Hematol Oncol; 2000; 17(7):527-40. PubMed ID: 11033728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using health-related quality of life measures to predict cardiac function in survivors exposed to anthracyclines.
    Ginsberg JP; Cnaan A; Zhao H; Clark BJ; Paridon SM; Chin AJ; Rychik J; Hogarty AN; Barber G; Rutkowski M; Kimball TR; DeLaat C; Steinherz LJ; Silber JH
    J Clin Oncol; 2004 Aug; 22(15):3149-55. PubMed ID: 15284267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise assessment of cardiac function in children and young adults before and after bone marrow transplantation.
    Larsen RL; Barber G; Heise CT; August CS
    Pediatrics; 1992 Apr; 89(4 Pt 2):722-9. PubMed ID: 1557268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise echocardiography reflects cumulative anthracycline exposure during childhood.
    Smibert E; Carlin JB; Vidmar S; Wilkinson LC; Newton M; Weintraub RG
    Pediatr Blood Cancer; 2004 Jun; 42(7):556-62. PubMed ID: 15127409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Exercise tolerance in patients after acute lymphoblastic leukemia treatment in childhood].
    Ostański M; Sońta-Jakimczyk D
    Wiad Lek; 2001; 54(11-12):650-5. PubMed ID: 11928552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia.
    Follin C; Thilén U; Osterberg K; Björk J; Erfurth EM
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3726-35. PubMed ID: 20484480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
    Tavernier E; Le QH; de Botton S; Dhédin N; Bulabois CE; Reman O; Vey N; Lhéritier V; Dombret H; Thomas X
    Cancer; 2007 Dec; 110(12):2747-55. PubMed ID: 17963265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Exercise cardiorespiratory parameters in children motivated to physical activity after treatment for acute lymphoblastic leukemia].
    Vizinová H; Malincíková J; Klásková E; Wiedermann J
    Cas Lek Cesk; 2002 Aug; 141(15):491-3. PubMed ID: 12226917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-invasive evaluation of cardiovascular system in patients after 3 to 5 years since the completion of acute lymphoblastic leukemia treatment].
    Ostański M; Sońta-Jakimczyk D; Hicke-Roberts A; Danek K
    Wiad Lek; 1998; 51 Suppl 4():113-8. PubMed ID: 10731953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies.
    Zerra P; Cochran TR; Franco VI; Lipshultz SE
    Expert Opin Pharmacother; 2013 Aug; 14(11):1497-513. PubMed ID: 23705955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.